REGISTRATION

Local Scientific Organizer

Prof. Alessandro Padovani
School of Neurology, University of Brescia

Scientific and Organizing Committee

Alessandro Padovani
Barbara Borroni
Alberto Benussi
Andrea Pilotto
University of Brescia (Italy)

Organizing Secretariat

Siena Congress
Via del Rastrello, 7 – 53100 Siena
Tel. 0577 286003 email: info@sienacongress.it

CME - Continuing Medical Education (for italian participants)

The conference Provider is SIN. (Italian Society of Neurology cod. no. 1802).

Event ID: 1802-297988

Assigned Credits: 31,5

Application has been made for the awarding of accreditation to the Italian National Commission for Continuing Education in Medicine (ECM) of AGENAS (the Italian National Agency for Regional Health Services) for Italian partecipants and also for the European Agency for international delegates.

The course will be accredited for the following Professions:

Medical Doctor (Neurology, Geriatrics, Psychiatry, Psychotherapy)
Psychologist
Biologist
Physical Therapist
Biotechnologist
Pharmacologist

EACCME Acrreditation (for UEMS participants)
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 20 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Accreditation Letter Information

Course description

The Summer School “Biological and Clinical converging pathways in Alzheimer and Parkinson disease” is an opportunity for young neurologists who are interested in specializing in Neurodegenerative diseases to receive in-depth instruction from internationally-recognized experts. Students will attend large lectures and panel discussions with question and answer sessions and will have the opportunity to discuss clinical cases of atypical dementia and movement disorders and engage in a differential diagnosis with the international experts.

Learning objectives

Understand the common and divergent pathways across neurodegenerative diseases
• Propose a differential diagnosis for complex cases and propose specific clinical/imaging/neurophysiological or biological markers assessment
• Propose a symptomatic personalized treatment for dementia and movement disorder
• Understand the rationale and review the more recent evidences for new disease-modifying target therapies across neurodegenerative diseases

Registration Fees

Expiration date: September 3^rd 2020